Dr. Cristina Muniesa and Dr. Octavi Servitje, from the Dermatology Service of the Bellvitge University Hospital (HUB) and IDIBELL researchers, participated in this study that evaluates the use of topical pimecrolimus in mycosis fungoides and was published in the prestigious journal The Lancet Haematology.
The HUB-ICO-IDIBELL Biobank has renewed the certification for the ISO 9001 standard, a quality standard recognized nationally and internationally based on continuous process improvement, and that demonstrates the organization’s commitment to quality service and customer satisfaction.
The HUB-ICO-IDIBELL biobank renews the ISO 9001:2015 certification Read More »
Dr. Aurora Pujol from IDIBELL and Dr. Manel Estaller from the Josep Carreras Leukaemia Research Institute identified an epigenetic signature associated to the development of the Multisystem Inflammatory Syndrome in Children (MIS-C) after a SARS-CoV-2 virus infection.
Researchers from the Karolinska Institute in Sweden, in collaboration with Meritxell Rovira from IDIBELL, the P-CMRC, and the UB show that a recently identified molecule stimulates the formation of new insulin-producing cells in zebrafish and in mammalian tissues.
A study describes a new way to generate insulin-producing cells Read More »
Today, June 21, World ALS Day, the campaign “Ellas contra la ELA” ends, a women’s football solidarity competition for ALS research.
The “Ellas contra la ELA” campaign ends with more than 13.500 euros raised Read More »
Through a live experiment, researchers assessed the curiosity aroused by a new song and its impact on audience memory and decision-making.
One and a half year after its debut, the STARS Game project has just reached its midpoint, Thus, the four partners have already delivered two rounds of workshops and implementations. Everyone’s experience regarding the escape room ended up being very positive and rewarding.
The second round of STARS escape room implementations has been a success Read More »
A group from IDIBELL, Catalan Institute of Oncology, and the Spanish Lung Cancer Group (GECP) have shown that the combination of atezolizumab with carboplatin and pemetrexed is safe and effective as a first treatment option in a group of 40 patients.
A genome-wide association study in a family with two males with infertility due to globozoospermia allows the identification of the first case of compound heterozygosis for two different mutations in the DPY19L2 gene.
A new international consensus guideline based on scientific evidence represents an improvement in the diagnosis and treatment of patients with certain fibrosing lung diseases.
